Almirall
↗Barcelona, Spain (Ronda General Mitre, 151, Barcelona, 08022)
Almirall is a leading Spanish pharmaceutical company headquartered in Barcelona, founded in 1944. The company specializes in medical dermatology and develops innovative treatments for dermatological diseases including psoriasis, atopic dermatitis, actinic keratosis, and acne. Almirall has undergone a strategic transformation since 2013 when it pivoted to focus on medical dermatology following acquisitions like Aqua Pharmaceuticals. The company is now the leading European company in medical dermatology with an expanding biologics portfolio and a robust pipeline of novel therapeutics. Almirall operates a global network with over 1,800 employees, 15 subsidiaries, and distribution in over 100 countries across 5 continents.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Dermatology, Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:1001-5000
Revenue:€898.8M (2024)
Founded:1944
Ownership:public
Status:operating
FUNDING
Stage:Mature/Public Company
STOCK
Exchange:Spanish Stock Exchange (BME), NASDAQ (ADR)
Ticker:ALM (BME), ALMRY (NASDAQ ADR), LBTSF (NASDAQ)
PIPELINE
Stage:Phase 1, Phase 2, Phase 3, Commercial
Lead Drug Stage:Commercial (Ebglyss/Lebrikizumab - FDA approved, Ilumetri/Tildrakizumab - Commercial)
Modalities:Small molecule, Monoclonal antibodies (mAb), Biologics, Topical treatments
Active Trials:8
Trial Phases:Phase 1: 2 | Phase 2: 2 | Phase 3: 2
FDA Approvals:2
EMA Approvals:3
CORPORATE STRUCTURE
Subsidiaries:Aqua Pharmaceuticals
Key Partnerships:Eli Lilly - Partnership for lebrikizumab development and commercialization in atopic dermatitis, Sun Pharmaceuticals - Partnership for tildrakizumab development, Microsoft - Collaboration on generative AI for data analysis, Centre for Genomic Regulation (CRG) - Biomarker identification and disease modeling for atopic dermatitis and NMSC
COMPETITION
Position:Leader
Competitors:AbbVie Inc., Pfizer Inc., GSK plc, LEO Pharma A/S, Sun Pharmaceutical Industries Ltd., GALDERMA, Amgen Inc., Johnson & Johnson +5 more
LEADERSHIP
Key Executives:
Carlos Gallardo Pique - Chief Executive Officer & Chairman
Volker Koscielny - Chief Medical Officer
Karl Ziegelbauer - Chief Scientific Officer
Mercedes Diz - Chief Marketing Officer
Mike McClellan - Chief Financial Officer
Eloi Crespo Cervera - Chief Industrial Operations Officer
Paolo Cionini - Chief Commercial Officer, Europe & International
Esteve Conesa Panicot - Chief People & Culture Officer
Isabel Cristina Gomes - Chief Legal Officer & General Counsel
Paul Rittman - President & General Manager, Almirall US
Enrique De Leyva Pérez - Vice-Chair & Lead Independent Director
Daniel Ripley - Secretary
Scientific Founders:Antonio Gallardo Carrera, Víctor Almirall i Riu
Board Members:Carlos Gallardo Pique (Chairman), Enrique De Leyva Pérez (Vice-Chair & Lead Independent Director), Daniel Ripley (Secretary)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Almirall. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.